<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Avastin vs Lucentis for age-related wet macular degeneration</title>
	<atom:link href="http://onthepharm.net/2006/07/genentech-avastin-lucentis-pricing.html/feed" rel="self" type="application/rss+xml" />
	<link>http://onthepharm.net/2006/07/genentech-avastin-lucentis-pricing.html</link>
	<description>Life on the pharm</description>
	<pubDate>Fri, 21 Nov 2008 23:42:14 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.3</generator>
		<item>
		<title>By: Barry Wheeler</title>
		<link>http://onthepharm.net/2006/07/genentech-avastin-lucentis-pricing.html#comment-181433</link>
		<dc:creator>Barry Wheeler</dc:creator>
		<pubDate>Tue, 29 Jul 2008 16:48:26 +0000</pubDate>
		<guid isPermaLink="false">http://onthepharm.net/2006/07/genentech-avastin-lucentis-pricing.html#comment-181433</guid>
		<description>My mother had experienced wet macular degeneration and was told in April 2007 that the only available drug to her at that time in Canada was Avastin.  Without the Government paying for this treatment, it had a potential to bankrupt her, but friends, family and may strangers came together to raise the funds necessary.  Her last check-up was just days ago (July 2008) and the doctor has indicated that her wet AMD has halted, and she's getting new glasses because of her improved vision.

Advocate for this drug from all sources!  Seeing is a right!!!

Barry Wheeler
Age Related Macular Degeneration Support
http://www.amdsupport.ca</description>
		<content:encoded><![CDATA[<p>My mother had experienced wet macular degeneration and was told in April 2007 that the only available drug to her at that time in Canada was Avastin.  Without the Government paying for this treatment, it had a potential to bankrupt her, but friends, family and may strangers came together to raise the funds necessary.  Her last check-up was just days ago (July 2008) and the doctor has indicated that her wet AMD has halted, and she&#039;s getting new glasses because of her improved vision.</p>
<p>Advocate for this drug from all sources!  Seeing is a right!!!</p>
<p>Barry Wheeler<br />
Age Related Macular Degeneration Support<br />
<a href="http://www.amdsupport.ca" rel="nofollow">http://www.amdsupport.ca</a></p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Dr.B.Dinesh Baliga</title>
		<link>http://onthepharm.net/2006/07/genentech-avastin-lucentis-pricing.html#comment-181320</link>
		<dc:creator>Dr.B.Dinesh Baliga</dc:creator>
		<pubDate>Wed, 09 Jul 2008 07:00:28 +0000</pubDate>
		<guid isPermaLink="false">http://onthepharm.net/2006/07/genentech-avastin-lucentis-pricing.html#comment-181320</guid>
		<description>Can you tell me which is better for my 69yr old mother who is going to be treated for Neovascular Glaucoma? Lucentis or Avastin.</description>
		<content:encoded><![CDATA[<p>Can you tell me which is better for my 69yr old mother who is going to be treated for Neovascular Glaucoma? Lucentis or Avastin.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: RJS</title>
		<link>http://onthepharm.net/2006/07/genentech-avastin-lucentis-pricing.html#comment-9741</link>
		<dc:creator>RJS</dc:creator>
		<pubDate>Tue, 16 Jan 2007 13:45:41 +0000</pubDate>
		<guid isPermaLink="false">http://onthepharm.net/2006/07/genentech-avastin-lucentis-pricing.html#comment-9741</guid>
		<description>I was talking to a friend of mine who is a compounding pharmacist, who makes Avastin to ARWMD, and he said that Lucentis doesn't really work, and that Avastin is far superior.

Interesting anecdote.</description>
		<content:encoded><![CDATA[<p>I was talking to a friend of mine who is a compounding pharmacist, who makes Avastin to ARWMD, and he said that Lucentis doesn&#039;t really work, and that Avastin is far superior.</p>
<p>Interesting anecdote.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: lucille hicks</title>
		<link>http://onthepharm.net/2006/07/genentech-avastin-lucentis-pricing.html#comment-9428</link>
		<dc:creator>lucille hicks</dc:creator>
		<pubDate>Sun, 14 Jan 2007 13:57:25 +0000</pubDate>
		<guid isPermaLink="false">http://onthepharm.net/2006/07/genentech-avastin-lucentis-pricing.html#comment-9428</guid>
		<description>My husband recently had the avastin shot in his eye to treat macular degeneration, as well as rubiosis. It was a last resort, as he is just 48 years old. Yes, I said Avastin, NOT lucentis, and it seems to be improving his once non existant vision. Price Gouging is exactly what it seems to be, and we have gone into this with our eyes WIDE open.</description>
		<content:encoded><![CDATA[<p>My husband recently had the avastin shot in his eye to treat macular degeneration, as well as rubiosis. It was a last resort, as he is just 48 years old. Yes, I said Avastin, NOT lucentis, and it seems to be improving his once non existant vision. Price Gouging is exactly what it seems to be, and we have gone into this with our eyes WIDE open.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Avastin to be tested against Lucentis in new government study :: OnThePharm</title>
		<link>http://onthepharm.net/2006/07/genentech-avastin-lucentis-pricing.html#comment-125</link>
		<dc:creator>Avastin to be tested against Lucentis in new government study :: OnThePharm</dc:creator>
		<pubDate>Sun, 16 Jul 2006 14:39:03 +0000</pubDate>
		<guid isPermaLink="false">http://onthepharm.net/2006/07/genentech-avastin-lucentis-pricing.html#comment-125</guid>
		<description>[...] One of my more popular entries by search engine traffic has been my Avastin v Lucentis post. Well Lucentis is back in the news: The U.S. government is considering an unusual study that pits two Genentech Inc. drugs against the same disease, jeopardizing almost $1 billion in estimated annual sales for the world&#8217;s second-largest biotechnology company. [...]</description>
		<content:encoded><![CDATA[<p>[...] One of my more popular entries by search engine traffic has been my Avastin v Lucentis post. Well Lucentis is back in the news: The U.S. government is considering an unusual study that pits two Genentech Inc. drugs against the same disease, jeopardizing almost $1 billion in estimated annual sales for the world&#039;s second-largest biotechnology company. [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
